What is Ascentage Pharma Group International - ADR Annual Revenue?

Ascentage Pharma Group International - ADR Annual Revenue rose 341.77%, in the last year to $980.65 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Ascentage Pharma Group International - ADR Annual Net Profit?

Ascentage Pharma Group International - ADR Annual Net Profit rose 56.2% in the last year to $405.43 M. Its sector's average net profit growth for the last fiscal year was -11.09%.

What is Ascentage Pharma Group International - ADR Stock Price?

Ascentage Pharma Group International - ADR Stock Price rose 40.39% and underperformed its sector by 15.08% in the past year.

What is Ascentage Pharma Group International - ADR Debt to Equity Ratio?

Ascentage Pharma Group International - ADR Debt to Equity Ratio of 6.32 is higher than 1. This implies that company assets are financed through debt.

What is Ascentage Pharma Group International - ADR Return on Equity(ROE)?

Ascentage Pharma Group International - ADR Return on Equity(ROE) for the last financial year was -249.8%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Ascentage Pharma Group International - ADR Mutual Fund Holding?

Ascentage Pharma Group International - ADR Mutual Fund Holding remained the same in the last quarter at 0%.

What is Ascentage Pharma Group International - ADR Interest Coverage Ratio?

Ascentage Pharma Group International - ADR Interest Coverage Ratio is -5.13, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Ascentage Pharma Group International - ADR Institutional Holding?

Ascentage Pharma Group International - ADR Institutional Holding increased by 0.27% in the last quarter to 0.27.

Ascentage Pharma Group International - ADR XNAS: AAPG

Ascentage Pharma Group International - ADR Live Share Price Today, Share Analysis and Chart

Name: Ascentage Pharma Group International - ADR: Is Infosys Ltd. worth buying?
Item: Ascentage Pharma Group International - ADR
Rating: 0.66741675
Author: Trendlyne DVM scores

about

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing ther...

24.40 -0.95 (-3.75%)

43.53% Gain from 52W Low

16,331 XNAS Volume

XNAS 30 May, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

0.2 / 100

Technically Bearish

26.5 / 100

28

1Yr Price target upside is 15%

2 analysts

Ascentage Pharma Group Int... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Ascentage Pharma Group International - ADR FAQ

How is Ascentage Pharma Group International - ADR today?

Ascentage Pharma Group International - ADR today is trading in the red, and is down by -3.75% at 24.40.

How has Ascentage Pharma Group International - ADR performed historically?

Ascentage Pharma Group International - ADR is currently trading down -3.75% on an intraday basis. In the past week the stock fell -7.85%. stock has been up 28.22% in the past quarter and rose 40.39% in the past year. You can view this in the overview section.